Writer's Palmyra Creative aims to add depth, variety, and originality to its outputs
Writer has launched Palmyra Creative, a new AI model designed to produce more creative and engaging outputs. According to Writer, Palmyra Creative can be combined with the company's specialized models to bring creative writing to domains such as finance and healthcare.
Generative AI company Writer has developed a new model tailored to support users in tasks requiring creative thinking and writing. According to Writer, Many LLMs are not suited for tasks like strategy mapping and brainstorming because their outputs have become almost characteristically one-dimensional, repetitive, and dull. To address this issue, Writer has launched Palmyra Creative, a model that can generate more engaging and original text.
Reportedly, rather than attempting to obtain more diverse outputs by scaling the amount of data the model was trained on, Writer focused on modifying how the model draws relationships among the tokens it sees during training. By using this approach, Writer was able to keep the costs down. The company is known for developing strategies to model training, including using synthetic data, that enable it to build performant models at a fraction of the cost paid by rivals like OpenAI. Palmyra Creative follows Palmyra X 004, a model trained mostly using synthetic data, costing Writer approximately $700,000.
Palmyra Creative can be used alone or as part of a system with any of Writer's specialized models, like Palmyra Med for healthcare or Palmyra Fin for finance. To ensure that Palmyra Creative's outputs remain factual and accurate, Writer's claim detection mode becomes essential. Writer has often lauded claim detection as the secret to making its generative AI platform immune to hallucinations, given that it allows users to find any claims that Writer can't verify. Palmyra Creative is available via Writer's API, its no-code tools, Writer's AI Studio, and as an NVIDIA NIM inference microservice.
The Palmyra Creative launch follows Writer's $200 million Series C funding round co-led by Premji Invest, Radical Ventures, and existing investor ICONIQ Growth, which took place a little over a month ago.